Literature DB >> 27986841

Financial burden of health care for Buruli ulcer patients in Nigeria: the patients' perspective.

Joseph N Chukwu1, Anthony O Meka1, Charles C Nwafor1, Daniel C Oshi1, Nelson O Madichie1, Ngozi Ekeke1, Moses C Anyim1, Alphonsus Chukwuka1, Mbah Obinna1, Julie Adegbesan1, Martin Njoku2, Festus O Soyinka3, Adebola O Adelokiki3, Isreal O Enemuoh4, Patrick I Okolie4, Joseph E Edochie4, Jonah B Offor5, Joseph Ushaka5, Kingsley N Ukwaja6.   

Abstract

BACKGROUND: The economic burden of Buruli ulcer for patients has not been well-documented. This study assessed the costs of Buruli ulcer care to patients from the onset of illness to diagnosis and to the end of treatment.
METHODS: This was a cross-sectional cost of illness study conducted among patients with Buruli ulcer in four States in Nigeria between July and September 2015. A structured questionnaire was used to collect data on the patients' characteristics, household income and out-of-pocket costs of care.
RESULTS: Of 92 patients surveyed, 54 (59%) were older than 15years, 49 (53%) were males, and 86 (93%) resided in a rural area. The median (IQR) direct medical and non-medical cost per patient was US$124 (50-282) and US$3 (3-6); corresponding to 149% and 4% of the patients' median monthly household income, respectively. The overall direct costs per patient was US$135 (58-327), which corresponded to 162% of median monthly household income, with pre-diagnosis costs accounting for 94.8% of the total costs. The direct costs of Buruli ulcer care were catastrophic for 50% of all patients/households - the rates of catastrophic costs for Buruli ulcer care was 66% and 19% for patients belonging to the lowest and highest income quartiles, respectively.
CONCLUSIONS: Direct costs of Buruli ulcer diagnosis and treatment are catastrophic to a substantial proportion of patients and their families.
© The Author 2016. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved.For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Buruli ulcer; Cost of illness; Health economics; Illness costs; Mycobacterium ulcerans; Nigeria

Mesh:

Year:  2016        PMID: 27986841     DOI: 10.1093/inthealth/ihw056

Source DB:  PubMed          Journal:  Int Health        ISSN: 1876-3405            Impact factor:   2.473


  9 in total

1.  Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin.

Authors:  Roch Christian Johnson; Emma Sáez-López; Esaï Sèdjro Anagonou; Godwin Gérard Kpoton; Adjimon Gilbert Ayelo; Ronald Sètondji Gnimavo; Franck Zinsou Mignanwande; Jean-Gabin Houezo; Ghislain Emmanuel Sopoh; Juliet Addo; Lindsay Orford; Georgios Vlasakakis; Nandita Biswas; Felix Calderon; Oscar Della Pasqua; Anna Gine-March; Zaida Herrador; Alfonso Mendoza-Losana; Gabriel Díez; Israel Cruz; Santiago Ramón-García
Journal:  Trials       Date:  2022-07-08       Impact factor: 2.728

2.  Factors associated with catastrophic health expenditure in sub-Saharan Africa: A systematic review.

Authors:  Paul Eze; Lucky Osaheni Lawani; Ujunwa Justina Agu; Linda Uzo Amara; Cassandra Anurika Okorie; Yubraj Acharya
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

3.  Implementation of a decentralized community-based treatment program to improve the management of Buruli ulcer in the Ouinhi district of Benin, West Africa.

Authors:  Arnaud Setondji Amoussouhoui; Ghislain Emmanuel Sopoh; Anita Carolle Wadagni; Roch Christian Johnson; Paulin Aoulou; Inès Elvire Agbo; Jean-Gabin Houezo; Micah Boyer; Mark Nichter
Journal:  PLoS Negl Trop Dis       Date:  2018-03-12

4.  Report of a series of 82 cases of Buruli ulcer from Nigeria treated in Benin, from 2006 to 2016.

Authors:  Gilbert Adjimon Ayelo; Esai Anagonou; Anita Carolle Wadagni; Yves Thierry Barogui; Ange Dodji Dossou; Jean Gabin Houezo; Julia Aguiar; Roch Christian Johnson; Raoul Saizonou; Kingsley Asiedu; Ghislain Emmanuel Sopoh
Journal:  PLoS Negl Trop Dis       Date:  2018-03-09

5.  Mapping suitability for Buruli ulcer at fine spatial scales across Africa: A modelling study.

Authors:  Hope Simpson; Earnest Njih Tabah; Richard O Phillips; Michael Frimpong; Issaka Maman; Edwin Ampadu; Joseph Timothy; Paul Saunderson; Rachel L Pullan; Jorge Cano
Journal:  PLoS Negl Trop Dis       Date:  2021-03-03

Review 6.  The cross-cutting contribution of the end of neglected tropical diseases to the sustainable development goals.

Authors:  Mathieu Bangert; David H Molyneux; Steve W Lindsay; Christopher Fitzpatrick; Dirk Engels
Journal:  Infect Dis Poverty       Date:  2017-04-04       Impact factor: 4.520

7.  Assessment of community knowledge, attitude, and stigma of Buruli ulcer disease in Southern Nigeria.

Authors:  Charles Chukwunalu Nwafor; Anthony Meka; Joseph Ngozi Chukwu; Ngozi Ekeke; Chukwuka Alphonsus; Obinna Mbah; Nelson Okechukwu Madichie; Ufuoma Aduh; Matthew Ogbeifo; Bola Olubakin IseOluwa-Adelokiki; Joseph Ezebunafor Edochie; Joseph Ushaka; Kingsley Nnanna Ukwaja
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

8.  Caregiver burden in Buruli ulcer disease: Evidence from Ghana.

Authors:  Yaw Ampem Amoako; Nancy Ackam; John-Paul Omuojine; Michael Ntiamoah Oppong; Abena Gyawu Owusu-Ansah; Mohammed Kabiru Abass; George Amofa; Elizabeth Ofori; Michael Frimpong; Freddie Bailey; David Hurst Molyneux; Richard Odame Phillips
Journal:  PLoS Negl Trop Dis       Date:  2021-06-01

9.  The cost of illness for childhood clinical pneumonia and invasive pneumococcal disease in Nigeria.

Authors:  Julie Jemutai; Ifedayo M Adetifa; Aishatu Lawal Adamu; Boniface Karia; Musa M Bello; Mahmoud G Jahun; Safiya Gambo; John Ojal; Anthony Scott
Journal:  BMJ Glob Health       Date:  2022-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.